DAY 1: Press Note (10 October 2026)
PGIMER Chandigarh conducted National CME "Radiopharmaceuticals: Beyond Boundaries "
CHANDIGARH,12.10.26-On Chandigarh, 10 October 2026, The Department of Nuclear Medicine, PGIMER Chandigarh, inaugurated a two-day National CME on "Radiopharmaceuticals: Beyond Boundaries", at the APC Auditorium. The CME brings together leading clinicians, scientists and industry experts from across India and abroad. Prof. Sanjay Jain, Dean, PGIMER, inaugurated the programme as Chief Guest.
Day-1
The theme of the CME is "Exploring Innovation, Enabling Theranostics, Transforming Patient Care". It looks at how radioactive medicines are changing the way diseases such as cancer are diagnosed and treated. These medicines can find a disease and then deliver treatment directly to diseased cells, sparing healthy tissue.
Other Session Topics were:
Laboratory research and drug screening behind new radiopharmaceuticals
Targeted internal radiation therapy for liver cancer
Alpha-particle therapy and precision biopsy
Breast cancer imaging
The growing role of Artificial Intelligence in nuclear medicine
Faculties from AIIMS New Delhi, SGPGI Lucknow, Tata Memorial Hospital and PGIMER, University college hospital, London K GE health care as well as from, shared their expertise.
DAY 2: (11 October 2026)
From Laboratory to Market: PGIMER CME Concludes with Focus on Innovation, IPR and Start-ups
Chandigarh, 11 October 2026: The two-day National CME "Radiopharmaceuticals: Beyond Boundaries", organised by the Department of Nuclear Medicine, PGIMER Chandigarh, concluded today. The final day centred on a key question for Indian healthcare: how can research ideas become real products that benefit patients?
The day began with a session on next-generation theranostics. Experts discussed emerging treatment isotopes such as Terbium-161 and Actinium-225. These isotopes promise more powerful and precise cancer therapy.
The Symposium on Intellectual Property Rights, Regulatory Requirements and Commercialisation:
Patents and technology transfer: Experts from the Punjab State Council for Science & Technology explained how researchers can file and protect patents, and how a technology moves from the laboratory to the market.
Medical start-ups: Speakers from Panjab University and PGIMER shared practical guidance on building start-ups and turning a concept into a commercial product.
Regulation and IP in healthcare: Industry experts explained India's regulatory pathway for radiopharmaceutical research and clinical trials, and why intellectual property protection matters in healthcare innovation.
These sessions gave doctors and scientists the knowledge to protect their discoveries and take them to patients faster.
A special session on, "Youngsters: Powering the Next Generation of Theranostics", gave young researchers a platform to present their work. Their topics included targeted imaging for surgery and antibody-based therapy for HER2-positive breast cancer.
The CME concluded with "PGIMER Chandigarh at a Glance", followed by feedback and a vote of thanks. The organisers expressed confidence that the discussions will help strengthen India's capabilities in radiopharmaceutical research, innovation and patient care.